희귀 혈우병 인자 시장은 2023-2028년 2억 860만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 연평균 10.04%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 희귀 혈우병 인자 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 새로운 치료 기술의 승인, 비용 효율적이고 고품질의 의료 솔루션의 채택, 정부의 적극적인 노력 등에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024년 |
| 종료 연도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 전년 대비[2024년] |
8.88% |
| CAGR |
10.04% |
| 증분 금액 |
2억 860만 달러 |
이 보고서는 유전자 치료의 등장이 향후 몇 년 동안 희귀 혈우병 인자 시장 성장을 주도하는 주요 요인 중 하나라고 분석했습니다. 또한, 치료법 개발을 위한 기술 혁신과 새로운 전략에 대한 R&D의 증가는 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 시장 상황
제3장 시장 규모 평가
- 시장 정의
- 시장 부문 분석
- 시장 규모 2023년
- 시장 전망 2023-2028년
제4장 시장 규모 실적
- 희귀 혈우병 인자 세계 시장 2018-2022년
- 방법별 부문 분석 2018-2022년
- 지역별 부문 분석 2018-2022년
- 국가별 부문 분석 2018-2022년
제5장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제6장 시장 세분화 : 방법별
- 시장 세분화
- 비교 : 방법별
- 신선 동결 혈장 : 시장 규모와 예측 2023-2028년
- 인자 농축물 : 시장 규모와 예측 2023-2028년
- 동결침전제제 : 시장 규모와 예측 2023-2028년
- 기타 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 방법별
제7장 고객 상황
제8장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측 2023-2028년
- 유럽 : 시장 규모와 예측 2023-2028년
- 아시아 : 시장 규모와 예측 2023-2028년
- 기타 : 시장 규모와 예측 2023-2028년
- 미국 : 시장 규모와 예측 2023-2028년
- 독일 : 시장 규모와 예측 2023-2028년
- 영국 : 시장 규모와 예측 2023-2028년
- 캐나다 : 시장 규모와 예측 2023-2028년
- 일본 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 지역 상황별
제9장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제10장 경쟁 상황
제11장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Aptevo Therapeutics Inc.
- Bayer AG
- CSL Ltd.
- F. Hoffmann La Roche Ltd.
- Grifols SA
- Novo Nordisk AS
- Octapharma AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
제12장 부록
ksm
The rare hemophilia factors market is forecasted to grow by USD 208.6 mn during 2023-2028, accelerating at a CAGR of 10.04% during the forecast period. The report on the rare hemophilia factors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by approval of new treatment techniques, introduction of cost-effective and high-quality medical solutions, and favorable government initiatives.
Technavio's rare hemophilia factors market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 8.88% |
| CAGR | 10.04% |
| Incremental Value | $208.6 mn |
By Method
- Fresh frozen plasma
- Factor concentrates
- Cryoprecipitate
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advent of gene therapy as one of the prime reasons driving the rare hemophilia factors market growth during the next few years. Also, increase in technological innovations and R and D of novel strategies to develop therapeutics will lead to sizable demand in the market.
The report on the rare hemophilia factors market covers the following areas:
- Rare hemophilia factors market sizing
- Rare hemophilia factors market forecast
- Rare hemophilia factors market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rare hemophilia factors market vendors that include Alnylam Pharmaceuticals Inc., Aptevo Therapeutics Inc., Bayer AG, Bio Products Laboratory Ltd., CSL Ltd., F. Hoffmann La Roche Ltd., Genentech Inc., Grifols SA, Gyre Therapeutics Inc., Intermountain Healthcare, Kedrion Spa, Novo Nordisk AS, Octapharma AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., The Johns Hopkins Health System Corp., UCSF Health, uniQure NV, and Versiti. Also, the rare hemophilia factors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Method
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Rare Hemophilia Factors Market 2018 - 2022
- Historic Market Size - Data Table on Global Rare Hemophilia Factors Market 2018 - 2022 ($ million)
- 4.2 Method segment analysis 2018 - 2022
- Historic Market Size - Method Segment 2018 - 2022 ($ million)
- 4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Method
- 6.1 Market segments
- Chart on Method - Market share 2023-2028 (%)
- Data Table on Method - Market share 2023-2028 (%)
- 6.2 Comparison by Method
- Chart on Comparison by Method
- Data Table on Comparison by Method
- 6.3 Fresh frozen plasma - Market size and forecast 2023-2028
- Chart on Fresh frozen plasma - Market size and forecast 2023-2028 ($ million)
- Data Table on Fresh frozen plasma - Market size and forecast 2023-2028 ($ million)
- Chart on Fresh frozen plasma - Year-over-year growth 2023-2028 (%)
- Data Table on Fresh frozen plasma - Year-over-year growth 2023-2028 (%)
- 6.4 Factor concentrates - Market size and forecast 2023-2028
- Chart on Factor concentrates - Market size and forecast 2023-2028 ($ million)
- Data Table on Factor concentrates - Market size and forecast 2023-2028 ($ million)
- Chart on Factor concentrates - Year-over-year growth 2023-2028 (%)
- Data Table on Factor concentrates - Year-over-year growth 2023-2028 (%)
- 6.5 Cryoprecipitate - Market size and forecast 2023-2028
- Chart on Cryoprecipitate - Market size and forecast 2023-2028 ($ million)
- Data Table on Cryoprecipitate - Market size and forecast 2023-2028 ($ million)
- Chart on Cryoprecipitate - Year-over-year growth 2023-2028 (%)
- Data Table on Cryoprecipitate - Year-over-year growth 2023-2028 (%)
- 6.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 6.7 Market opportunity by Method
- Market opportunity by Method ($ million)
- Data Table on Market opportunity by Method ($ million)
7 Customer Landscape
- 7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
- 8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 8.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 8.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 8.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
- 9.1 Market drivers
- 9.2 Market challenges
- 9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 9.4 Market opportunities/restraints
10 Competitive Landscape
- 10.1 Overview
- 10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 10.3 Landscape disruption
- Overview on factors of disruption
- 10.4 Industry risks
- Impact of key risks on business
11 Competitive Analysis
- 11.1 Companies profiled
- 11.2 Market positioning of companies
- Matrix on companies position and classification
- 11.3 Aptevo Therapeutics Inc.
- Aptevo Therapeutics Inc. - Overview
- Aptevo Therapeutics Inc. - Product / Service
- Aptevo Therapeutics Inc. - Key offerings
- 11.4 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- 11.5 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- 11.6 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 11.7 Grifols SA
- Grifols SA - Overview
- Grifols SA - Business segments
- Grifols SA - Key news
- Grifols SA - Key offerings
- Grifols SA - Segment focus
- 11.8 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key news
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- 11.9 Octapharma AG
- Octapharma AG - Overview
- Octapharma AG - Product / Service
- Octapharma AG - Key offerings
- 11.10 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- 11.11 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- 11.12 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
12 Appendix
- 12.1 Scope of the report
- 12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 12.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 12.4 Research methodology
- 12.5 Data procurement
- 12.6 Data validation
- 12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 12.8 Data synthesis
- 12.9 360 degree market analysis
- 360 degree market analysis
- 12.10 List of abbreviations
